Monsanto shareholders back Bayer deal, CEO hopeful of U.S. approval

CHICAGO, Dec 13 (Reuters) - Shareholders of U.S. seeds and

agrochemicals company Monsanto Co approved the company's

$66 billion acquisition by Bayer AG on Tuesday, a

deal that still requires regulatory approval to close as

expected in late 2017.

Read more